Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Alto Neuroscience Inc (NYSE: ANRO) was $11.55 for the day, up 3.77% from the previous closing price of $11.13. In other words, the price has increased by $3.77 from its previous closing price. On the day, 0.56 million shares were traded. ANRO stock price reached its highest trading level at $11.56 during the session, while it also had its lowest trading level at $10.62.
Ratios:
Our analysis of ANRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 18.43 and its Current Ratio is at 18.43. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on September 29, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On October 23, 2024, Wedbush Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $29 to $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANRO now has a Market Capitalization of 356997696 and an Enterprise Value of 190459072.
Stock Price History:
The Beta on a monthly basis for ANRO is 3.29, which has changed by 1.3863637 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, ANRO has reached a high of $15.18, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is 70.00%, while the 200-Day Moving Average is calculated to be 201.16%.
Shares Statistics:
ANRO traded an average of 1.50M shares per day over the past three months and 693810 shares per day over the past ten days. A total of 27.07M shares are outstanding, with a floating share count of 23.85M. Insiders hold about 11.91% of the company’s shares, while institutions hold 82.01% stake in the company. Shares short for ANRO as of 1760486400 were 2248165 with a Short Ratio of 1.50, compared to 1757894400 on 1641280. Therefore, it implies a Short% of Shares Outstanding of 2248165 and a Short% of Float of 10.5399996.
Earnings Estimates
The stock of Alto Neuroscience Inc (ANRO) is currently drawing attention from 1 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.6, with high estimates of -$0.6 and low estimates of -$0.6.
Analysts are recommending an EPS of between -$2.31 and -$2.88 for the fiscal current year, implying an average EPS of -$2.46. EPS for the following year is -$2.29, with 1 analysts recommending between -$2.29 and -$2.29.
